Survival analysis in breast cancer using proteomic data from four independent datasets
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Survival analysis in breast cancer using proteomic data from four independent datasets
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-18
DOI
10.1038/s41598-021-96340-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein biomarkers for subtyping breast cancer and implications for future research
- (2018) Claudius Mueller et al. Expert Review of Proteomics
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progress on Identifying and Characterizing the Human Proteome: 2018 Metrics from the HUPO Human Proteome Project
- (2018) Gilbert S. Omenn et al. JOURNAL OF PROTEOME RESEARCH
- Ki67 is a Graded Rather than a Binary Marker of Proliferation versus Quiescence
- (2018) Iain Miller et al. Cell Reports
- Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival
- (2018) Wei Tang et al. Genome Medicine
- Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers
- (2017) Takayuki Iwamoto et al. Oncotarget
- The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival
- (2016) Ines Vasconcelos et al. BREAST
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition
- (2016) Eric W. Deutsch et al. NUCLEIC ACIDS RESEARCH
- Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer
- (2016) Magali Michaut et al. Scientific Reports
- Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
- (2015) Naoko Honma et al. BMC CANCER
- Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients
- (2015) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
- (2015) Tommaso De Marchi et al. Molecular Oncology
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Lessons learned from the intrinsic subtypes of breast cancer in the quest for precision therapy
- (2014) J. H. Norum et al. BRITISH JOURNAL OF SURGERY
- RE: Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
- (2014) N. Bakinde et al. JNCI-Journal of the National Cancer Institute
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination
- (2014) Juan A Vizcaíno et al. NATURE BIOTECHNOLOGY
- Antibody-based proteomics and biomarker research-Current status and limitations
- (2014) Corinne Solier et al. PROTEOMICS
- Linking cancer genome to proteome: NCI's investment into proteogenomics
- (2014) Robert C. Rivers et al. PROTEOMICS
- Treatment of Estrogen Receptor-Positive Breast Cancer
- (2013) F. Lumachi et al. CURRENT MEDICINAL CHEMISTRY
- TCPA: a resource for cancer functional proteomics data
- (2013) Jun Li et al. NATURE METHODS
- The application of quantification techniques in proteomics for biomedical research
- (2012) Eva Rodríguez-Suárez et al. MASS SPECTROMETRY REVIEWS
- From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma
- (2012) Bryce P. Portier et al. New Biotechnology
- Identification of a claudin-4 and E-cadherin score to predict prognosis in breast cancer
- (2011) Attila M. Szasz et al. CANCER SCIENCE
- Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer
- (2011) N. Hayashi et al. ONCOLOGIST
- BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
- (2010) S-J Dawson et al. BRITISH JOURNAL OF CANCER
- Options and considerations when selecting a quantitative proteomics strategy
- (2010) Bruno Domon et al. NATURE BIOTECHNOLOGY
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
- (2008) Robert L. Camp et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started